Teladoc Health, Inc. (NYSE:TDOC) Shares Sold by Monaco Asset Management SAM

Monaco Asset Management SAM decreased its position in Teladoc Health, Inc. (NYSE:TDOCFree Report) by 52.9% in the 4th quarter, Holdings Channel reports. The fund owned 410,000 shares of the health services provider’s stock after selling 460,791 shares during the period. Teladoc Health accounts for 0.5% of Monaco Asset Management SAM’s holdings, making the stock its 21st biggest holding. Monaco Asset Management SAM’s holdings in Teladoc Health were worth $3,727,000 at the end of the most recent quarter.

A number of other large investors have also added to or reduced their stakes in TDOC. Versant Capital Management Inc boosted its holdings in Teladoc Health by 313.8% in the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock valued at $29,000 after purchasing an additional 2,441 shares during the last quarter. Whipplewood Advisors LLC bought a new position in shares of Teladoc Health in the 4th quarter worth about $29,000. Lindbrook Capital LLC boosted its stake in Teladoc Health by 78.9% in the fourth quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after acquiring an additional 1,612 shares during the period. PNC Financial Services Group Inc. boosted its position in Teladoc Health by 22.0% during the 4th quarter. PNC Financial Services Group Inc. now owns 7,978 shares of the health services provider’s stock valued at $73,000 after purchasing an additional 1,439 shares during the period. Finally, KBC Group NV boosted its holdings in shares of Teladoc Health by 72.3% during the fourth quarter. KBC Group NV now owns 8,849 shares of the health services provider’s stock valued at $80,000 after acquiring an additional 3,714 shares during the period. 76.82% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on the company. Oppenheimer decreased their price objective on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating for the company in a report on Friday, January 24th. Piper Sandler lowered their price objective on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research note on Thursday, February 27th. Royal Bank of Canada boosted their target price on Teladoc Health from $11.00 to $12.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. The Goldman Sachs Group cut their price target on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating on the stock in a report on Monday, March 3rd. Finally, Bank of America increased their price objective on Teladoc Health from $11.50 to $13.50 and gave the stock a “neutral” rating in a research note on Wednesday, February 12th. Eleven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $11.26.

Check Out Our Latest Stock Report on Teladoc Health

Teladoc Health Price Performance

NYSE TDOC opened at $8.50 on Friday. The stock’s 50-day moving average is $10.60 and its two-hundred day moving average is $9.68. Teladoc Health, Inc. has a fifty-two week low of $6.76 and a fifty-two week high of $15.68. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. The firm has a market cap of $1.48 billion, a P/E ratio of -1.47 and a beta of 1.27.

Teladoc Health (NYSE:TDOCGet Free Report) last released its earnings results on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The firm had revenue of $640.49 million for the quarter, compared to analyst estimates of $639.44 million. On average, analysts anticipate that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Teladoc Health Company Profile

(Free Report)

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

Read More

Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOCFree Report).

Institutional Ownership by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.